Rich has been a serial entrepreneur, having been CEO of both private and public companies. He has also founded and managed two successful Venture Capital firms, De Novo Ventures and Saratoga Ventures. De Novo has raised $650MLN in three funds and has invested in 44 companies spanning Medical Devices and Biotechnology.

Dr. Khalid Mentak is a serial entrepreneur and inventor. He has founded and led several successful medical device companies including, Advanced Vision Science (AVS), Key Medical Technologies (KMTech), and Adoptics AG. In 1997, Dr. Mentak founded AVS to develop the first glistening-free foldable acrylic intraocular lens.

Geoff Dillon has been involved in pioneering numerous medical device technologies and business models during his tenure spanning 30 years, addressing seven different medical specialties along the way. He most recently founded and was CEO of Medical Entrepreneurs II (ME2) in northern California, becoming the first, class III generic medical device company in the world, first foray being that of replicating gold standard replacement heart valves.

Ivan brings over 15 years of Wall Street experience in Capital Markets, Alternative Investments, and Wealth Management to the Catalyst Group. Ivan holds an MBA from Mercer University and Masters Degree in Material Science Engineering with emphasis in Biomedical Engineering from the University of Florida. His field of study was Radio Frequency Plasma surface modification of biopolymers used in intraocular lens applications.

www.zuehlke.com